Alkunani, A.S. et al. 2026. Claudin-6 (CLDN6) and Folate Receptor Alpha (FRα) Targeted Antibody-Drug Conjugates: Bypassing Platinum Resistance and Tumor Heterogeneity in High-Grade Serous Ovarian Carcinoma. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 11, 2 (Oct. 2026), 140–151. DOI:https://doi.org/10.54133/ajms.v11i2.3258.